MedPath
NMPA Approval

Ranitidine Hydrochloride Injection

国药准字H20033880

July 15, 2022

Drug Information

盐酸雷尼替丁注射液

注射剂

2ml:50mg(按C13H22N4O3S计)

化学药品

July 15, 2022

Company Information

Applicant Company

Manufacturing Company

兖州市振华北路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸雷尼替丁注射液 - NMPA 批准文号 | MedPath